The adoption of rapid sterility testing has significant benefits to the pharmaceutical industry; providing early notification of control drifts, a non-subjective answer to the sterility test and a faster time to product release. However the challenges of adoption can be daunting.
By enhancing the benefits of regulatory interactions in the development phases, a complex post-approval regulatory change can be mitigated, however with limited material available, the outlined strategy provides a robust way forward to adopt rapid sterility and capture the benefits.
Rapid methods- The Next Phase : A Framework For Multi-Product Adoption Of Rapid Sterility Testing is hosted by BioPharma Webinars.
Rapid methods- The Next Phase : A Framework For Multi-Product Adoption Of Rapid Sterility Testing is scheduled for Wednesday, September 29, 2021.
Registration or viewing is completed on BioPharma Webinars's website. UPCOMING sends visitors using referral parameters.
This is an online webinar.
The event covers Compliance.
EndedMay 29, 2026
BioPharma Webinars
EndedMay 5, 2026
BioPharma Webinars
EndedDec 5, 2025
BioPharma Webinars